Bharat Immunologicals shows prevailing Real Value of 7.8393 per share. The current price of the firm is 8.7. At this time the firm appears to be overvalued. Macroaxis approximates value of Bharat Immunologicals from analyzing the firm fundamentals such as Return On Equity of
(10.18)% and Profit Margin of (12.30)% as well as examining its technical indicators and Probability Of Bankruptcy. In general, we favor to go long with undervalued instruments and to trade away overvalued instruments since at some point assets prices and their ongoing real values will blend.
|Horizon||30 Days Login to change|
Bharat Immunologicals Biologicals Corp Ltd is rated second in price to earning category among related companies. It is rated below average in beta category among related companies . The ratio of Price to Earning to Beta for Bharat Immunologicals Biologicals Corp Ltd is about 611.35
|Price to Earning ( times )|
Bharat Immunologicals is relatively risky asset. Calculation of real value of Bharat Immunologicals is based on 2 months time horizon. Increasing Bharat Immunologicals time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.